Insider · CIK 0001760123

Pauls Dietrich John

Reports to the SEC for 1 company · MINNEAPOLIS, MN

sec.gov

Transactions

Companies

Filings

CIK

0001760123

Forms 4 and 5

Insider transactions

14 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-10	DMACDiaMedica Therapeutics Inc.A Award	Director, President & CEO	AAward	+60.2K sh	—	—	128,791
2026-06-01	DMACDiaMedica Therapeutics Inc. · Stock Option (right to buy)A Award	Director, President & CEO	AAward	+380K sh	—	—	380,000
2025-06-01	DMACDiaMedica Therapeutics Inc. · Stock Option (right to buy)A Award	Director, President & CEO	AAward	+600K sh	—	—	600,000
2024-06-01	DMACDiaMedica Therapeutics Inc. · Stock Option (right to buy)A Award	Director, President & CEO	AAward	+300K sh	—	—	300,000
2023-06-23	DMACDiaMedica Therapeutics Inc.P Purchase	Director, President & CEO	PPurchase	+12.8K sh	$3.91	+$50K	68,591
2023-06-01	DMACDiaMedica Therapeutics Inc. · Stock option (right to buy)A Award	Director, President & CEO	AAward	+181K sh	—	—	181,000
2022-11-16	DMACDiaMedica Therapeutics Inc.P Purchase	Director, President & CEO	PPurchase	+20K sh	$1.21	+$24.2K	55,804
2022-06-01	DMACDiaMedica Therapeutics Inc. · Stock Option (right to buy)A Award	Director, President & CEO	AAward	+177K sh	—	—	177,000
2021-08-16	DMACDiaMedica Therapeutics Inc.P Purchase	Director, President & CEO	PPurchase	+5,000 sh	$3.14	+$15.7K	35,804
2021-07-28	DMACDiaMedica Therapeutics Inc. · Stock Option (right to buy)A Award	Director, President & CEO	AAward	+175K sh	—	—	175,000
2020-06-01	DMACDiaMedica Therapeutics Inc. · Stock Option (right to buy)A Award	Director, President & CEO	AAward	+56K sh	—	—	56,000
2019-08-16	DMACDiaMedica Therapeutics Inc.P Purchase	Director, President & CEO	PPurchase	+1,000 sh	$2.68	+$2,676.9	30,804
2019-06-24	DMACDiaMedica Therapeutics Inc. · Stock Option (right to buy)A Award	Director, President & CEO	AAward	+264K sh	—	—	264,000
2018-12-11	DMACDiaMedica Therapeutics Inc.P Purchase	Director, President & CEO	PPurchase	+5,000 sh	$4.00	+$20K	29,804

Recent filings

Accepted (ET)
Aug 124
Pauls Dietrich John0001760123-26-000004
SEC(opens sec.gov)
Jun 34
Pauls Dietrich John0001760123-26-000002
SEC(opens sec.gov)
Jun 34
Pauls Dietrich John0001437749-25-019294
SEC(opens sec.gov)
Jun 34
Pauls Dietrich John0001235802-24-000050
SEC(opens sec.gov)
Jun 264
Pauls Dietrich John0001235802-23-000072
SEC(opens sec.gov)
Jun 24
Pauls Dietrich John0001235802-23-000061
SEC(opens sec.gov)
Nov 164
Pauls Dietrich John0001235802-22-000121
SEC(opens sec.gov)
Jun 24
Pauls Dietrich John0001235802-22-000076
SEC(opens sec.gov)
Aug 164
Pauls Dietrich John0001235802-21-000098
SEC(opens sec.gov)
Jul 294
Pauls Dietrich John0001235802-21-000092
SEC(opens sec.gov)
Jun 24
Pauls Dietrich John0001235802-20-000053
SEC(opens sec.gov)
Aug 164
Pauls Dietrich John0001235802-19-000105
SEC(opens sec.gov)
Jun 264
Pauls Dietrich John0001235802-19-000064
SEC(opens sec.gov)
Dec 114
Pauls Dietrich John0001235802-18-000182
SEC(opens sec.gov)

Companies

DiaMedica Therapeutics Inc.Director, President & CEODMAC

Address

301 CARLSON PARKWAY SUITE 210

MINNEAPOLIS, MN, 55305